BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2009
View Archived Issues
Novel Raf kinase B inhibitors claimed by Wyeth
Read More
Novel inhibitors of sirtuin described by MethylGene for cancer treatment
Read More
Dr Reddy's Laboratories claims novel tetracycline derivatives as antiinfective agents
Read More
Amgen and Epix Pharmaceuticals claim novel compounds for the treatment of autoimmune conditions
Read More
Activity of HCV p7 ion channel activity inhibitor BIT-225 described
Read More
First-in-human phase I/II trial results with adenoviral-based gene transfer for HF published
Read More
Cannabinoid CB2 modulators claimed by Kalypsys as analgesics
Read More
Impax provides clinical update on IPX-066 and IPX-056
Read More
Forest and Cypress launch Savella for fibromyalgia
Read More
Novel fumagillin-derived polymer displays in vitro antiangiogenic and in vivo antitumor activity
Read More
GlaxoSmithKline presents data on GSK-1838705A, an oncolytic IGF-1R inhibitor
Read More
GlaxoSmithKline launches alli in Europe for weight loss
Read More
Activity of EGFR, HER2 inhibitor S-222611 delineated in vitro and in vivo
Read More
Peregrine reports preliminary phase II data for bavituximab in lung cancer
Read More
Snapshots: Recent results from clinical studies of telaprevir in hepatitis C
Read More
Phytopharm initiates safety and tolerability study of PYM-50028 in PD
Read More
Psylin Neurosciences begins development of PSN-004 for depression
Read More
Tolarex receives approval to initiate phase I/IIa trial of a treatment for GVHD
Read More
Immuron will acquire immune modulation technology from Hadassah Medical Center
Read More
GSK and Stiefel agree to create specialist dermatology business
Read More
Pharmasset voluntarily terminates phase III QUASH clinical trials of clevudine in hepatitis B
Read More
Amira initiates phase I trial for novel DP2 antagonist, AM-211
Read More
Ardea Biosciences reports positive results from a phase I hyperuricemia study
Read More
Elusys' anthrax anti-toxin, Anthim, enters second phase I trial
Read More
Merck Serono launches Kuvan in Europe
Read More
Sanofi-aventis launches Apidra SoloSTAR insulin delivery device in the U.S.
Read More